Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain - Wikidata - wikimedia - TriplyDB

Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain

Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain

http://www.wikidata.org/entity/Q35285811

about

Role of exosomes/microvesicles in the nervous system and use in emerging therapies Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survival Role of Envelopment in the HEV Life Cycle Extracellular Vesicles in Physiology, Pathology, and Therapy of the Immune and Central Nervous System, with Focus on Extracellular Vesicles Derived from Mesenchymal Stem Cells as Therapeutic Tools Illuminating the physiology of extracellular vesicles Extracellular vesicles round off communication in the nervous system Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane Vesicles Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation Exosomes as Novel Regulators of Adult Neurogenic Niches Texosome-based drug delivery system for cancer therapy: from past to present Extracellular vesicles from infected cells: potential for direct pathogenesis Tumor-derived exosomes in cancer progression and treatment failure Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche Exosomes as mediators of neuroinflammation Extracellular-vesicle type of volume transmission and tunnelling-nanotube type of wiring transmission add a new dimension to brain neuro-glial networks Epigenetic impact of curcumin on stroke prevention Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes.Adult Stem Cell Therapy for Stroke: Challenges and Progress Stem cell-derived exosomes as a therapeutic tool for cardiovascular disease Therapeutic Potential of Curcumin for the Treatment of Brain Tumors Cell or cell membrane-based drug delivery systems Gliomas and the vascular fragility of the blood brain barrier Extracellular vesicle-mediated delivery of molecular compounds into gametes and embryos: learning from nature Using exosomes, naturally-equipped nanocarriers, for drug delivery Exosomes for repair, regeneration and rejuvenation Curcumin inhibits mitochondrial injury and apoptosis from the early stage in EAE mice The roles and implications of exosomes in sarcoma NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface.Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1.Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes.Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters.Biodistribution and function of extracellular miRNA-155 in mice.Extracellular vesicles from neural stem cells transfer IFN-γ via Ifngr1 to activate Stat1 signaling in target cells.Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using (99m)Tc-HMPAO.Presence of Cx43 in extracellular vesicles reduces the cardiotoxicity of the anti-tumour therapeutic approach with doxorubicin Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer.

P2860

Q21129255-03AACD69-2BFB-4F44-B03E-7F049599F24E Q21133553-1FF9BC6E-D26F-4EB7-AE59-CCFE845F59A3 Q24294497-5A4B433F-6E88-4FEE-8CED-31EA5165E215 Q26739943-5BCE9887-BD70-4888-8DCE-43C4A97945CB Q26747560-465AFB46-93DE-40EF-A0D2-E9009C9E656C Q26753090-2290ADB4-5407-45EB-ABD3-A17893EF2186 Q26764878-1D46298D-A45B-4682-82D4-A0AA8081A3E7 Q26767267-046D0DC4-12DF-49BA-9CA7-21F0114F2B4B Q26767270-6F355B3C-0463-4CFF-B5D3-7D42AFC75597 Q26770754-14DE339C-613B-4D1A-BE68-AC86F0714797 Q26772836-C609E879-17C2-40A0-8FC5-D76972805BB8 Q26778833-140C681D-BC55-4DAB-A96E-EE2C52AA2BD6 Q26779430-31F13638-3B13-4AE2-BB26-9E823CCD4323 Q26785408-29101CC7-F15B-46BC-A0DE-CD1047B057B9 Q26802187-DA727EA7-5AD9-4E41-ACEC-CECFFED9B8AB Q26861645-AD14B218-558C-452A-9F2E-A2BC99CAC91C Q26865141-1286E8D9-188B-4EEF-B898-1845A6F0D191 Q26995083-A2FF8866-3F6E-4A07-9111-C40F9EE79BCF Q26995412-510A7EEC-C597-46E9-A60C-AFCB52C39636 Q27026606-8DC44409-6CD6-4A7E-B379-3D67126CEE49 Q27319925-B4410E34-DAF0-4A78-A484-1CDD720E2043 Q28066235-57EE6031-D7B9-47C9-9F85-0F9DD37EFB8E Q28071466-9183B767-C38B-4672-BD12-C561A73EF53A Q28071572-93F15DB7-8440-4DB1-B0A7-7AA439EA995B Q28080710-8DA90471-CD82-4DC5-B6CB-6719B2D74E9A Q28081953-1A9D8AD3-B017-4E98-8687-A3B30EF3246C Q28083833-705A9AF3-657A-4142-A1E5-E12025243362 Q28265872-DF014A71-C425-4EB7-9E39-46584501F7DD Q28272609-80349409-9E1C-493C-998F-4B7BF23880B4 Q28385855-46470537-69E7-49C2-B903-0AB1E488BF95 Q30249353-2350AAC2-A997-4D1C-8C55-8A2AE996B3F8 Q30352890-597BAE47-983F-4C20-A3AE-348798F65AEF Q30532710-A8AB0C35-13F3-4655-A089-DAD5176B02D3 Q30533859-17467C52-77F6-4AF1-8F8D-B5DF3ACA04F2 Q30650963-97117D68-B0A7-4227-954F-A776EEF0FABB Q30652180-8F47C00F-27C1-40D4-8439-D19ADEDC68ED Q30665140-885DD79F-D872-4AE9-AFFA-630AEF0B622E Q30670597-33A6D253-7699-45E2-9847-0FA43F8EB23D Q30817598-48E3F20B-CBE1-4281-B89C-BF2DCEC664B3 Q33588257-C9C88252-E195-4298-A6E1-7D0C35653AF9

P2860

Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain

http://www.wikidata.org/entity/Q35285811

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Treatment of brain inflammator ...... the nasal region to the brain

@ast

Treatment of brain inflammator ...... the nasal region to the brain

@en

type

label

Treatment of brain inflammator ...... the nasal region to the brain

@ast

Treatment of brain inflammator ...... the nasal region to the brain

@en

prefLabel

Treatment of brain inflammator ...... the nasal region to the brain

@ast

Treatment of brain inflammator ...... the nasal region to the brain

@en

P1433

Q35285811-A980C3BC-3A17-4258-A51A-A869E154DE20

P1476

Q35285811-37526F29-F191-4F48-9D49-8F6994AD38BE

P2093

Q35285811-08FA92AF-EF61-4678-9418-7726714CF96D

Q35285811-27891039-30DE-4795-83DC-0FF70F379F3B

Q35285811-646F77C1-D7E4-4C04-87AA-BE66EB2F3106

Q35285811-6A316944-FF52-44FE-A6B5-C69918DCA924

Q35285811-8BA45145-F8C3-4895-9737-A55C2BA36D73

Q35285811-A4437C4B-E105-4E62-9F23-B11919D829AA

Q35285811-B1473CD0-BEFD-428F-978B-18BC885F685B

Q35285811-B72D7E23-8898-4C71-9D27-8C40E2672325

Q35285811-D054B579-D573-4242-9A3F-CE6743FD8402

Q35285811-D30FAB66-BD41-4F47-9931-510969ADC257

P2860

Q35285811-05D91D4E-7DF6-4775-BA82-A9AC03A1B25A

Q35285811-18D28B60-2434-4EC2-9AC5-2FC8CFC39D1E

Q35285811-1A66CB70-B5ED-4FD3-BBFA-164C0D5D3642

Q35285811-1B1BC59A-E003-4D00-9991-157A1B4009AB

Q35285811-1FD7FDF3-DE70-4518-94CB-F27EE6C2746B

Q35285811-2583EF4F-76F1-4E17-A20A-42C53DB2DB5B

Q35285811-2E417EFD-D692-4D84-A05E-33C90B962C8C

Q35285811-38D29146-7FF0-4FDC-AB75-BDF801721111

Q35285811-3EE8C13C-F18E-4443-93B6-03AC4D1FFCE0

Q35285811-3EFFDCB8-D2F8-48A4-9E31-BB83E5687244

P304

Q35285811-AC7C73BF-FDEE-4C87-89F9-52FCEB4F6397

P31

Q35285811-22F79AC6-00EF-439E-A1CA-4C42A57FFF7D

P356

Q35285811-1E6A6156-DB86-4EB0-9AA2-A8B557D7CA66

P433

Q35285811-6D8E59F6-F970-4AE2-9F31-AAE5D6B77DE0

P478

Q35285811-06701717-08BA-47EF-A662-9B13ADBA4EE4

P577

Q35285811-D0AA5E51-EA16-4B6A-B5C9-C6265C0CFE95

P5875

Q35285811-3CBFE57C-5764-47D8-BB35-7CB282754F21

P698

Q35285811-1D288133-2703-4081-AEF5-94E3A8E7CE4C

P921

Q35285811-8727F95A-8218-4DF6-8001-D9F8360A42E4

P932

Q35285811-4EAA9DE5-42C5-4E8F-852E-BD9D206F14DF

P356

P1433

Molecular Therapy

P1476

Treatment of brain inflammator ...... the nasal region to the brain

@en

P2093

Donald Miller

http://www.w3.org/2001/XMLSchema#string

Dongmei Sun

http://www.w3.org/2001/XMLSchema#string

Huang-Ge Zhang

http://www.w3.org/2001/XMLSchema#string

Jiangyao Mu

http://www.w3.org/2001/XMLSchema#string

Lawrence Steinman

http://www.w3.org/2001/XMLSchema#string

Lifeng Zhang

http://www.w3.org/2001/XMLSchema#string

Robert C Axtell

http://www.w3.org/2001/XMLSchema#string

Shuangqin Zhang

http://www.w3.org/2001/XMLSchema#string

Songwen Ju

http://www.w3.org/2001/XMLSchema#string

William Grizzle

http://www.w3.org/2001/XMLSchema#string

P2860

LPA receptors: subtypes and biological actions

Membrane vesicles as conveyors of immune responses

Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells.

Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures

Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.

A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes

Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy

Chemopreventive properties of curcumin.

Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals.

P304

1769-1779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2011.164

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51634996

http://www.w3.org/2001/XMLSchema#string

P698

21915101

http://www.w3.org/2001/XMLSchema#string

P921

P932

3188748

http://www.w3.org/2001/XMLSchema#string